CoChat

Adeno-Associated Virus Capsid Structure Drives CD4-Dependent CD8+ T Cell Response to Vector Encoded Proteins

Open access
Mays, Lauren E, Vandenberghe, Luk H, Xiao, Ru, Bell, Peter, Nam, Hyun-Joo, Agbandje-McKenna, Mavis, Wilson, James M · 2009 · The Journal of Immunology
Cited by 99

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

The immunological sequelae of adeno-associated virus (AAV)-mediated gene transfer in vivo is quite complex. In murine models, most AAV capsids are associated with minimal or dysfunctional T cell responses to antigenic transgene products. In this study we compared T cell activation against AAV2/8 and AAV2/rh32.33 vectors expressing nuclear-targeted LacZ (nLacZ), GFP, or firefly luciferase in murine skeletal muscle. We show that, unlike AAV8, AAVrh32.33 yields qualitatively and quantitatively robust T cell responses to both the capsid and transgene product. AAV2/rh32.33.CB.nLacZ, but not AAV2/8, drives a high degree of cellular infiltration and a loss of detectable transgene expression in C57BL/6 mice. However, cellular immunity to AAVrh32.33 is ablated in the absence of CD4, CD40L, or CD28, permitting stable β-galactosidase expression. Treatment of CD40L−/− mice with the CD40 agonist, FGK45, failed to restore the CD8 response to AAV2/rh32.33.nLacZ, suggesting that additional factors are involved. Our results suggest that specific domains within the AAVrh32.33 capsid augment the adaptive response to both capsid and transgene Ags in a CD4-dependent pathway involving CD40L signaling and CD28 costimulation. Structural comparison of the AAV8 and rh32.33 capsids has identified key differences that may drive differential immunity by affecting tropism, Ag presentation or the activation of innate immunity. This murine model of AAV-mediated cytotoxicity allows us to delineate the mechanism of viral immune activation, which is relevant to the translation of AAV technology in higher order species.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.0803965

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 45

  1. 2005, Gene therapy: twenty-first century medicine., 711
  2. 2008, Immunity to adeno-associated virus vectors in animals and humans: a continued challenge., 808
  3. 1999, Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector., 56
  4. 2005, Helper functions required for wild type and recombinant adeno-associated virus growth., 265
  5. 1965, Association of 20-millimicron particles with adenoviruses., 271
  6. 1965, Adenovirus-associated defective virus particles., 754
  7. 1996, Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3., 208
  8. 2005, Structure of adeno-associated virus type 4., 5047
  9. 1998, Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2., 309
  10. 2002, Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy., 11854
  11. 2003, Adeno-associated viruses undergo substantial evolution in primates during natural infections., 6081
  12. 2004, Clades of adeno-associated viruses are widely disseminated in human tissues., 6381
  13. 2004, Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein., 375
  14. 2009, Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses., 381
  15. 1966, Small deoxyribonucleic acid-containing viruses (picodnavirus group)., 331
  16. 1993, Structure, sequence, and function correlations among parvoviruses., 491
  17. 2007, Structure of adeno-associated virus serotype 8, a gene therapy vector., 12260
  18. 2000, Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism., 8635
  19. 2000, Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX., 225
  20. 2005, Systemic protein delivery by muscle-gene transfer is limited by a local immune response., 4226
  21. 2005, Immune responses to adeno-associated virus vectors., 323
  22. 2005, An optimized protocol for detection of E. coli β-galactosidase in lung tissue following gene transfer., 77
  23. 2006, The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling., 195
  24. 2004, Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions., 2256
  25. 2004, COOT: model-building tools for molecular graphics., 2126
  26. 1991, Improved methods for building protein models in electron density maps and the location of errors in these models., 110
  27. 2007, Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer., 1132
  28. 2001, Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors., 269
  29. 2001, The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice., 1813
  30. 1999, Immune response to green fluorescent protein: implications for gene therapy., 1305
  31. 2003, Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment., 4911
  32. 2003, Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection., 2053
  33. 1994, CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection., 8056
  34. 1995, Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models., 8178
  35. 1998, CTL effector function within the central nervous system requires CD4+ T cells., 2896
  36. 1998, Help for cytotoxic-T-cell responses is mediated by CD40 signalling., 478
  37. 1998, A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell., 474
  38. 2000, Immature dendritic cells acquire CD8+ cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli., 145
  39. 1996, Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation., 747
  40. 1996, CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40., 1862
  41. 2002, A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory., 2060
  42. 2000, CD40-independent pathways of T cell help for priming of CD8+ cytotoxic T lymphocytes., 541
  43. 2000, Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses., 3689
  44. 2001, Role of CD28/CD80–86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection., 612
  45. 1995, New perspectives of CD28–B7-mediated T cell costimulation., 555

Cited by

See all 99

Metadata

Authors
Mays, L. E., Vandenberghe, L. H., Xiao, R., Bell, P., Nam, H.-J., Agbandje-McKenna, M., & Wilson, J. M.
Venue
The Journal of Immunology
Published
2009-05
Volume
182
Issue
10
Pages
6051-6060
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1808026750
Cited by
99
References
19
FWCI
4.46
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adeno-Associated Virus Capsid Structure Drives CD4-Dependent CD8+ T Cell Response to Vector Encoded Proteins. https://app.cochat.ai/papers/10.4049/jimmunol.0803965
The paper
Mays, L. E., Vandenberghe, L. H., Xiao, R., Bell, P., Nam, H.-J., Agbandje-McKenna, M., & Wilson, J. M. (2009). Adeno-Associated Virus Capsid Structure Drives CD4-Dependent CD8+ T Cell Response to Vector Encoded Proteins. The Journal of Immunology. https://doi.org/10.4049/jimmunol.0803965

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.